InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.58
(
0.03%
)
US TECH 100
18,971.60
(
0.17%
)
Dow Jones
41,606.18
(
-0.04%
)
Brent Oil
72.28
(
-1.42%
)
Bitcoin
59,588.67
(
-1.18%
)
Post# of 253142
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: rkrw post# 121731

Thursday, 06/16/2011 9:20:02 AM

Thursday, June 16, 2011 9:20:02 AM

Post# of 253142
Are many companies still originating Phase 1 trials using an IV formula, or is this a thing of the past now for most companies?

It would seem like a complete waste of time to develop a drug in IV formula, go through an entire Phase 1, and then have to develop a tablet/oral pill, and do another separate trial to make sure the efficacy is the same.

I know this is off-subject from the original post, sorry.

Anyway, '113 seems a little more attractive at this point - not that it ever wasn't in the first place.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up